Impact of overactive bladder on retrograde ejaculation

ArticleAçık Erişim

Özet

Purpose: To evaluate the impact of overactive bladder disorder on patients diagnosed with retrograde ejaculation. Materials and Methods: Retrospective analysis of prospective collected database made. Questionnaires conducted in urology polyclinics in five different centers. Main Outcome Measure(s): International Index of Erectile Function - 5 (IIEF - 5), Overactive Bladder 8 - Question Awareness Tool (OAB - V8), urodynamics, semen analysis. The participants of the study were n = 120 patients. There was retrograde ejaculation (RE) in only n = 47 patients (non / minimal symptomatic patients), n = 73 patients had RE and overactive (OAB) complaints (symptomatic patients) and received anticholinergic treatment (trospium), n = 37 control group patients who only had OAB and received an anticholinergic. Results: While no difference was observed in overactive bladder examination and urodynamic values between the non / minimal symptomatic group and the symptomatic group (p > 0.05), sperm was detected and identified as fructose positive in post - ejaculation urine in the symptomatic group. Thus, it was possible to demonstrate the differences between symptomatic patients and non - symptomatic patients. Consequently, following three - month daily treatment with trospium 30 mg 2 x 1 in the control group and the symptomatic group, it was observed that an evident increase was observed in the sperm count and ejaculate volume in the symptomatic group and that no change was observed in the control group (p < 0.05). Conclusion: This clinical study is the first of its kind in terms of revealing the coexistence of RE with OAB upon performing urodynamics and showing that treatment is possible in selected patients. © 2018 Brazilian Society of Urology.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14040Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorSalvarci, Ahmet
dc.contributor.authorKarabakan, Mehmet
dc.contributor.authorBozkurt, Aliseydi
dc.contributor.authorHirik, Erkan
dc.contributor.authorAktas, Binhan Kagan
dc.date.accessioned2026-10-18T20:28:50.007892883Z
dc.date.available2026-10-18T20:28:50.007892883Z
dc.date.issued2018
dc.description.abstractPurpose: To evaluate the impact of overactive bladder disorder on patients diagnosed with retrograde ejaculation. Materials and Methods: Retrospective analysis of prospective collected database made. Questionnaires conducted in urology polyclinics in five different centers. Main Outcome Measure(s): International Index of Erectile Function - 5 (IIEF - 5), Overactive Bladder 8 - Question Awareness Tool (OAB - V8), urodynamics, semen analysis. The participants of the study were n = 120 patients. There was retrograde ejaculation (RE) in only n = 47 patients (non / minimal symptomatic patients), n = 73 patients had RE and overactive (OAB) complaints (symptomatic patients) and received anticholinergic treatment (trospium), n = 37 control group patients who only had OAB and received an anticholinergic. Results: While no difference was observed in overactive bladder examination and urodynamic values between the non / minimal symptomatic group and the symptomatic group (p > 0.05), sperm was detected and identified as fructose positive in post - ejaculation urine in the symptomatic group. Thus, it was possible to demonstrate the differences between symptomatic patients and non - symptomatic patients. Consequently, following three - month daily treatment with trospium 30 mg 2 x 1 in the control group and the symptomatic group, it was observed that an evident increase was observed in the sperm count and ejaculate volume in the symptomatic group and that no change was observed in the control group (p < 0.05). Conclusion: This clinical study is the first of its kind in terms of revealing the coexistence of RE with OAB upon performing urodynamics and showing that treatment is possible in selected patients. © 2018 Brazilian Society of Urology.
dc.identifier.doi10.1590/s1677-5538.ibju.2018.0225
dc.identifier.eissn1677-6119
dc.identifier.endpage980
dc.identifier.issn1677-5538
dc.identifier.issue5
dc.identifier.pmcidPMC6237516
dc.identifier.pmid30130018
dc.identifier.scopus2-s2.0-85054893283
dc.identifier.startpage972
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14040
dc.identifier.volume44
dc.identifier.wosWOS:000446097700017
dc.language.isoen
dc.publisherBrazilian Society of Urology
dc.relation.ispartofInternational Braz J Urol
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEjaculation
dc.subjectOveractive
dc.subjectUrinary Bladder
dc.subjectUrodynamics
dc.subjectAdult
dc.subjectCase-Control Studies
dc.subjectCholinergic Antagonists
dc.subjectHumans
dc.subjectMale
dc.subjectOligospermia
dc.subjectRetrospective Studies
dc.subjectSperm Count
dc.subjectUrinary Bladder, Overactive
dc.subjectcholinergic receptor blocking agent
dc.subjectcase control study
dc.subjectcomplication
dc.subjecthuman
dc.subjectoveractive bladder
dc.subjectpathophysiology
dc.subjectphysiology
dc.subjectretrospective study
dc.subjectspermatozoon count
dc.titleImpact of overactive bladder on retrograde ejaculation
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus2
rdl.citation.wos3
rdl.departmentDepartment of Urology, Erzincan University, Mengücek Gazi Research and Training Hospital, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)